Center for Regenerative Medicine, Boston University and Boston Medical Center, 670 Albany Street, 2(nd) Floor, Boston, MA 02118, USA; Department of Biomedical Engineering, Boston University, 44 Cummington Mall, Boston, MA 02215, USA.
Center for Regenerative Medicine, Boston University and Boston Medical Center, 670 Albany Street, 2(nd) Floor, Boston, MA 02118, USA; The Pulmonary Center and Department of Medicine, Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118, USA.
Stem Cell Reports. 2019 Sep 10;13(3):499-514. doi: 10.1016/j.stemcr.2019.07.014. Epub 2019 Aug 15.
Induced pluripotent stem cells (iPSCs) provide a potential source for the derivation of smooth muscle cells (SMCs); however, current approaches are limited by the production of heterogeneous cell types and a paucity of tools or markers for tracking and purifying candidate SMCs. Here, we develop murine and human iPSC lines carrying fluorochrome reporters (Acta2 and ACTA2, respectively) that identify Acta2/ACTA2 cells as they emerge in vitro in real time during iPSC-directed differentiation. We find that Acta2 and ACTA2 cells can be sorted to purity and are enriched in markers characteristic of an immature or synthetic SMC. We characterize the resulting GFP populations through global transcriptomic profiling and functional studies, including the capacity to form engineered cell sheets. We conclude that these reporter lines allow for generation of sortable, live iPSC-derived Acta2/ACTA2 cells highly enriched in smooth muscle lineages for basic developmental studies, tissue engineering, or future clinical regenerative applications.
诱导多能干细胞(iPSCs)为平滑肌细胞(SMCs)的衍生提供了潜在的来源;然而,目前的方法受到产生异质细胞类型和缺乏跟踪和纯化候选 SMC 的工具或标记物的限制。在这里,我们开发了携带荧光报告基因(Acta2 和 ACTA2,分别)的小鼠和人 iPSC 系,这些基因可以在 iPSC 定向分化过程中实时识别 Acta2/ACTA2 细胞在体外的出现。我们发现,Acta2 和 ACTA2 细胞可以被纯化,并富含特征为不成熟或合成 SMC 的标记物。我们通过全转录组谱分析和功能研究来表征所得的 GFP 群体,包括形成工程细胞片的能力。我们得出的结论是,这些报告基因系允许生成可分选的、活的 iPSC 衍生的 Acta2/ACTA2 细胞,这些细胞高度富集平滑肌谱系,可用于基础发育研究、组织工程或未来的临床再生应用。